In vitro and in silico evaluation of human serum albumin binding, blood-brain barrier permeability, and acetylcholinesterase inhibition by multi-target compounds with potential anti-Alzheimer’s disease properties
Alzheimer’s disease (AD) continues to pose a major global health challenge, with incidence rising sharply and current therapies offering only symptomatic relief. This study builds on prior work into six structurally diverse multi-target compounds (1–6) designed to modulate key pathological processes in AD. We have now combined experimental and computational approaches to determine a set of pharmac
